Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/25/1998 | EP0879600A1 Fructan containing composition for the prevention and treatment of colon cancer |
11/25/1998 | EP0879599A2 A topical preparation for treatment of erectile dysfunction comprising theophylline or aminophylline, isosorbide dinitrate and co-dergocrine mesylate |
11/25/1998 | EP0879597A1 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
11/25/1998 | EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects |
11/25/1998 | EP0879298A2 Methods and compositions for diagnosis of hyperhomocysteinemia |
11/25/1998 | EP0879294A1 Transduced human hematopoietic stem cells |
11/25/1998 | EP0879291A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
11/25/1998 | EP0879289A1 Human dnase resistant to actin inhibition |
11/25/1998 | EP0879288A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
11/25/1998 | EP0879286A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
11/25/1998 | EP0879285A1 Fas ligand fusion protein |
11/25/1998 | EP0879284A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
11/25/1998 | EP0879282A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
11/25/1998 | EP0879281A2 Methods and compositions for transforming dendritic cells and activating t cells |
11/25/1998 | EP0879274A1 Technical di- and triglyceride mixtures |
11/25/1998 | EP0879249A1 Modified inulin |
11/25/1998 | EP0879245A1 Synthetic il-10 analogues |
11/25/1998 | EP0879241A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
11/25/1998 | EP0879237A1 Isooxacephem derivatives |
11/25/1998 | EP0879236A1 Derivatives of camptothecin for use in treating cancer |
11/25/1998 | EP0879235A1 Purine and guanine derivatives |
11/25/1998 | EP0879234A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system |
11/25/1998 | EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists |
11/25/1998 | EP0879231A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
11/25/1998 | EP0879230A2 Optically active phenyl pyrimidine derivative as analgesic agent |
11/25/1998 | EP0879227A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
11/25/1998 | EP0879223A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
11/25/1998 | EP0879061A2 Spermatogenesis control |
11/25/1998 | EP0879059A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon |
11/25/1998 | EP0879058A1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
11/25/1998 | EP0879057A1 Granules from triazines |
11/25/1998 | EP0879056A1 MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN$m(3) AND RIBAVIRIN$m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES |
11/25/1998 | EP0879055A1 Inhibition of viral replication |
11/25/1998 | EP0879054A1 Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse |
11/25/1998 | EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
11/25/1998 | EP0879051A1 Rate-controlled transdermal administration of risperidone |
11/25/1998 | EP0879050A1 Captopril tablets |
11/25/1998 | EP0879035A1 Bismuth-containing compounds in topical dosage forms |
11/25/1998 | EP0842181A4 Membrane-permeant second messengers |
11/25/1998 | EP0840613B1 Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide |
11/25/1998 | EP0833636A4 Method for inhibiting neoplastic disease in mammals |
11/25/1998 | EP0759912B1 Di-oxadiazole derivatives as antihyperglycemic agents |
11/25/1998 | EP0711291B1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
11/25/1998 | EP0700283B1 Liquid antacid compositions |
11/25/1998 | EP0689458B1 Active-substance patch for releasing estradiol to the skin |
11/25/1998 | EP0669835B1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols |
11/25/1998 | EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant |
11/25/1998 | EP0654994B1 Use of cineol or menthol for the treament of asthma |
11/25/1998 | EP0652866B1 Azacyclic compounds |
11/25/1998 | EP0649303B1 Substituted arginines and substituted homoarginines and use thereof |
11/25/1998 | EP0624159B1 Pyridyl substituted imidazoles |
11/25/1998 | EP0621773B1 Formulation and use of carotenoids in treatment of cancer |
11/25/1998 | EP0620004B1 Medicinal composition |
11/25/1998 | EP0619808B1 3-hydroxypyridin-4-one derivatives as chelating agents |
11/25/1998 | EP0607252B1 Compositions for the treatment of hiv infection |
11/25/1998 | EP0606380B1 2-substituted quinolines for treating leishmanioses |
11/25/1998 | EP0526566B1 Treatment of erectile dysfunction |
11/25/1998 | CN1200147A Compounds and methods for immunotherapy and diagnosis of tuberculosis |
11/25/1998 | CN1200146A Compounds and methods for diagnosis of tuberculosis |
11/25/1998 | CN1200127A Novel opioid peptides |
11/25/1998 | CN1200126A Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
11/25/1998 | CN1200122A Lubeluzole N-oxide |
11/25/1998 | CN1200121A Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
11/25/1998 | CN1200120A Piperazino derivatives as neurokinin antagonists |
11/25/1998 | CN1200119A (Methylsulfonyl) phenyl-2-(5H)-furanones as cox-2 inhibitors |
11/25/1998 | CN1200115A Chiral methyl phenyl oxazolidinones |
11/25/1998 | CN1200106A Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
11/25/1998 | CN1200037A Chicken interleukin-15 and uses thereof |
11/25/1998 | CN1200036A Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
11/25/1998 | CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
11/25/1998 | CN1200033A Method of producing multi-layer medicaments in solid form for oral or rectal administration |
11/25/1998 | CN1200030A Topical compositions having improved skin feel |
11/25/1998 | CN1200025A Antiplaque oral composition |
11/25/1998 | CN1200017A Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
11/25/1998 | CN1199736A New process for preparation of azithromycin |
11/25/1998 | CN1199735A Preparation of highly pure crystalline form of cefuroxime axetil |
11/25/1998 | CN1199731A Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
11/25/1998 | CN1199613A Preparation having increased in vivo tolerability |
11/25/1998 | CN1199612A Preparation of new-type antimalarial drug artemisin methyl ether capsule |
11/25/1998 | CN1199611A Calcium replenishing chewing tablet |
11/25/1998 | CN1199610A Calcium replenishing instant granule |
11/25/1998 | CN1040877C New derivatives of erythromycin, their preparation process and their use as medicaments |
11/25/1998 | CN1040876C New derivatives of erythromycin, their preparation process, their use as medicaments |
11/25/1998 | CN1040874C Triazolopyridazine compounds and its preparation, composition with said compound as its active ingredient |
11/25/1998 | CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process |
11/25/1998 | CN1040840C Antibiotic embedding agent and preparing method |
11/24/1998 | US5840991 Antiatherosclerosis agents for lipid-lowering and antiperoxidative activity |
11/24/1998 | US5840990 Intermediates to carbocyclic nucleosides |
11/24/1998 | US5840979 Useful in the treatment and prevention of diseases in which cell death occurs by apoptosis |
11/24/1998 | US5840974 Metalloproteinase inhibitors |
11/24/1998 | US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors |
11/24/1998 | US5840938 20(S)-25-hydroxy vitamin D compounds |
11/24/1998 | US5840931 Antitumor agents |
11/24/1998 | US5840925 Trioxane dimer compounds having antiproliferative and antitumor activities |
11/24/1998 | US5840922 Reacting an amino-coumarin derivative with diethyl-ethoxymethylene malonate |
11/24/1998 | US5840921 Method for the preparation of aldol product 7B |
11/24/1998 | US5840918 Isoprenyl transferase inhibitors |
11/24/1998 | US5840916 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
11/24/1998 | US5840911 Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors |
11/24/1998 | US5840910 Pyridine derivatives having anti-ulcerative activity |